nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Haemoglobin—Tamoxifen—pancreatic cancer	0.0066	0.0066	CcSEcCtD
Cefprozil—Neutropenia—Sunitinib—pancreatic cancer	0.00657	0.00657	CcSEcCtD
Cefprozil—Haemorrhage—Tamoxifen—pancreatic cancer	0.00656	0.00656	CcSEcCtD
Cefprozil—Haemoglobin—Erlotinib—pancreatic cancer	0.00653	0.00653	CcSEcCtD
Cefprozil—Pharyngitis—Tamoxifen—pancreatic cancer	0.00652	0.00652	CcSEcCtD
Cefprozil—Haemorrhage—Erlotinib—pancreatic cancer	0.00649	0.00649	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00621	0.00621	CcSEcCtD
Cefprozil—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00621	0.00621	CcSEcCtD
Cefprozil—Erythema multiforme—Erlotinib—pancreatic cancer	0.00614	0.00614	CcSEcCtD
Cefprozil—Colitis—Docetaxel—pancreatic cancer	0.00612	0.00612	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00587	0.00587	CcSEcCtD
Cefprozil—Erythema—Tamoxifen—pancreatic cancer	0.00571	0.00571	CcSEcCtD
Cefprozil—Erythema—Erlotinib—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Cefprozil—Haemoglobin—Sunitinib—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Cefprozil—Haemorrhage—Sunitinib—pancreatic cancer	0.00562	0.00562	CcSEcCtD
Cefprozil—Eosinophilia—Fluorouracil—pancreatic cancer	0.00549	0.00549	CcSEcCtD
Cefprozil—Neutropenia—Irinotecan—pancreatic cancer	0.00541	0.00541	CcSEcCtD
Cefprozil—Pancytopenia—Gemcitabine—pancreatic cancer	0.00535	0.00535	CcSEcCtD
Cefprozil—Erythema multiforme—Sunitinib—pancreatic cancer	0.00532	0.00532	CcSEcCtD
Cefprozil—Neutropenia—Gemcitabine—pancreatic cancer	0.00527	0.00527	CcSEcCtD
Cefprozil—Pancytopenia—Fluorouracil—pancreatic cancer	0.00526	0.00526	CcSEcCtD
Cefprozil—Angioedema—Tamoxifen—pancreatic cancer	0.00522	0.00522	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00498	0.00498	CcSEcCtD
Cefprozil—Erythema—Sunitinib—pancreatic cancer	0.00489	0.00489	CcSEcCtD
Cefprozil—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00489	0.00489	CcSEcCtD
Cefprozil—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00469	0.00469	CcSEcCtD
Cefprozil—Haemoglobin—Irinotecan—pancreatic cancer	0.00465	0.00465	CcSEcCtD
Cefprozil—Haemorrhage—Irinotecan—pancreatic cancer	0.00463	0.00463	CcSEcCtD
Cefprozil—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00461	0.00461	CcSEcCtD
Cefprozil—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00457	0.00457	CcSEcCtD
Cefprozil—Haemoglobin—Gemcitabine—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Cefprozil—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Cefprozil—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Cefprozil—Haemorrhage—Gemcitabine—pancreatic cancer	0.00451	0.00451	CcSEcCtD
Cefprozil—Pharyngitis—Gemcitabine—pancreatic cancer	0.00448	0.00448	CcSEcCtD
Cefprozil—Angioedema—Sunitinib—pancreatic cancer	0.00447	0.00447	CcSEcCtD
Cefprozil—Haemoglobin—Fluorouracil—pancreatic cancer	0.00446	0.00446	CcSEcCtD
Cefprozil—Haemorrhage—Fluorouracil—pancreatic cancer	0.00444	0.00444	CcSEcCtD
Cefprozil—Pharyngitis—Fluorouracil—pancreatic cancer	0.0044	0.0044	CcSEcCtD
Cefprozil—Vaginal inflammation—Epirubicin—pancreatic cancer	0.0043	0.0043	CcSEcCtD
Cefprozil—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00427	0.00427	CcSEcCtD
Cefprozil—Convulsion—Sunitinib—pancreatic cancer	0.00424	0.00424	CcSEcCtD
Cefprozil—Insomnia—Tamoxifen—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Cefprozil—Insomnia—Erlotinib—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Cefprozil—Colitis—Epirubicin—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Cefprozil—Blood urea increased—Epirubicin—pancreatic cancer	0.00406	0.00406	CcSEcCtD
Cefprozil—Vaginal infection—Epirubicin—pancreatic cancer	0.00406	0.00406	CcSEcCtD
Cefprozil—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Cefprozil—Pain—Tamoxifen—pancreatic cancer	0.00399	0.00399	CcSEcCtD
Cefprozil—Vaginal inflammation—Doxorubicin—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Cefprozil—Pain—Erlotinib—pancreatic cancer	0.00395	0.00395	CcSEcCtD
Cefprozil—Erythema—Gemcitabine—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Cefprozil—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Cefprozil—Erythema—Fluorouracil—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Cefprozil—Colitis—Doxorubicin—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Cefprozil—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Cefprozil—Pancytopenia—Docetaxel—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Cefprozil—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00377	0.00377	CcSEcCtD
Cefprozil—Blood urea increased—Doxorubicin—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Cefprozil—Vaginal infection—Doxorubicin—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Cefprozil—Neutropenia—Docetaxel—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Cefprozil—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Cefprozil—Urticaria—Tamoxifen—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Cefprozil—Abdominal pain—Tamoxifen—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Cefprozil—Body temperature increased—Erlotinib—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Cefprozil—Abdominal pain—Erlotinib—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Cefprozil—Insomnia—Sunitinib—pancreatic cancer	0.00361	0.00361	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00354	0.00354	CcSEcCtD
Cefprozil—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Cefprozil—Pain—Sunitinib—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Cefprozil—Convulsion—Fluorouracil—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Cefprozil—Agranulocytosis—Docetaxel—pancreatic cancer	0.00333	0.00333	CcSEcCtD
Cefprozil—Confusional state—Irinotecan—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Cefprozil—Pruritus—Tamoxifen—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Cefprozil—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Cefprozil—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Cefprozil—Pruritus—Erlotinib—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Cefprozil—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Cefprozil—Haemoglobin—Docetaxel—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Cefprozil—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Cefprozil—Haemorrhage—Docetaxel—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Cefprozil—Diarrhoea—Tamoxifen—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Cefprozil—Confusional state—Fluorouracil—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Pharyngitis—Docetaxel—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Abdominal pain—Sunitinib—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Cefprozil—Body temperature increased—Sunitinib—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Cefprozil—Diarrhoea—Erlotinib—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Cefprozil—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Cefprozil—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00314	0.00314	CcSEcCtD
Cefprozil—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Cefprozil—Dizziness—Tamoxifen—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00306	0.00306	CcSEcCtD
Cefprozil—Dizziness—Erlotinib—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Cefprozil—Erythema multiforme—Docetaxel—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Cefprozil—Insomnia—Irinotecan—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Cefprozil—Vomiting—Tamoxifen—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Cefprozil—Hypersensitivity—Sunitinib—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Cefprozil—Rash—Tamoxifen—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Cefprozil—Dermatitis—Tamoxifen—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Cefprozil—Vomiting—Erlotinib—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Cefprozil—Somnolence—Irinotecan—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Cefprozil—Headache—Tamoxifen—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Cefprozil—Rash—Erlotinib—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Cefprozil—Dermatitis—Erlotinib—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Cefprozil—Insomnia—Gemcitabine—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Headache—Erlotinib—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Cefprozil—Insomnia—Fluorouracil—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Cefprozil—Somnolence—Gemcitabine—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Cefprozil—Pruritus—Sunitinib—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Cefprozil—Pain—Irinotecan—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00281	0.00281	CcSEcCtD
Cefprozil—Somnolence—Fluorouracil—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Cefprozil—Erythema—Docetaxel—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Cefprozil—Nausea—Tamoxifen—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Cefprozil—Pain—Gemcitabine—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Cefprozil—Nausea—Erlotinib—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Cefprozil—Diarrhoea—Sunitinib—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Cefprozil—Feeling abnormal—Irinotecan—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Cefprozil—Pain—Fluorouracil—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Cefprozil—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Cefprozil—Eosinophilia—Epirubicin—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Cefprozil—Dizziness—Sunitinib—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Cefprozil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Cefprozil—Abdominal pain—Irinotecan—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Cefprozil—Body temperature increased—Irinotecan—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Cefprozil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Cefprozil—Pancytopenia—Epirubicin—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Cefprozil—Vomiting—Sunitinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Cefprozil—Body temperature increased—Gemcitabine—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Cefprozil—Neutropenia—Epirubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Cefprozil—Rash—Sunitinib—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Cefprozil—Dermatitis—Sunitinib—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Cefprozil—Urticaria—Fluorouracil—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Cefprozil—Headache—Sunitinib—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Cefprozil—Body temperature increased—Fluorouracil—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Cefprozil—Eosinophilia—Doxorubicin—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Hypersensitivity—Irinotecan—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Cefprozil—Convulsion—Docetaxel—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Cefprozil—Drowsiness—Epirubicin—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Cefprozil—Nausea—Sunitinib—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Cefprozil—Pancytopenia—Doxorubicin—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Cefprozil—Neutropenia—Doxorubicin—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Cefprozil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Cefprozil—Confusional state—Docetaxel—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Cefprozil—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Cefprozil—Pruritus—Gemcitabine—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Cefprozil—Diarrhoea—Irinotecan—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Cefprozil—Agranulocytosis—Epirubicin—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Cefprozil—Pruritus—Fluorouracil—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Cefprozil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Cefprozil—Drowsiness—Doxorubicin—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Cefprozil—Diarrhoea—Gemcitabine—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Cefprozil—Dizziness—Irinotecan—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Cefprozil—Haemoglobin—Epirubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Cefprozil—Haemorrhage—Epirubicin—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Cefprozil—Diarrhoea—Fluorouracil—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Cefprozil—Pharyngitis—Epirubicin—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Cefprozil—Vomiting—Irinotecan—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Cefprozil—Dizziness—Fluorouracil—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Cefprozil—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00208	0.00208	CcSEcCtD
Cefprozil—Rash—Irinotecan—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Cefprozil—Dermatitis—Irinotecan—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Cefprozil—Headache—Irinotecan—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Cefprozil—Insomnia—Docetaxel—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Cefprozil—Erythema multiforme—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Vomiting—Gemcitabine—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Somnolence—Docetaxel—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Cefprozil—Rash—Gemcitabine—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Cefprozil—Dermatitis—Gemcitabine—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Cefprozil—Haemoglobin—Doxorubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefprozil—Headache—Gemcitabine—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Cefprozil—Vomiting—Fluorouracil—pancreatic cancer	0.002	0.002	CcSEcCtD
Cefprozil—Haemorrhage—Doxorubicin—pancreatic cancer	0.002	0.002	CcSEcCtD
Cefprozil—Rash—Fluorouracil—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Cefprozil—Dermatitis—Fluorouracil—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Cefprozil—Pharyngitis—Doxorubicin—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Cefprozil—Headache—Fluorouracil—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Cefprozil—Nausea—Irinotecan—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Cefprozil—Pain—Docetaxel—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Cefprozil—Nausea—Gemcitabine—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Cefprozil—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Cefprozil—Erythema—Epirubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Cefprozil—Feeling abnormal—Docetaxel—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Cefprozil—Nausea—Fluorouracil—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Cefprozil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Cefprozil—Tension—Epirubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Nervousness—Epirubicin—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Cefprozil—Abdominal pain—Docetaxel—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Cefprozil—Body temperature increased—Docetaxel—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Cefprozil—Erythema—Doxorubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Cefprozil—Agitation—Epirubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Cefprozil—Tension—Doxorubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Cefprozil—Nervousness—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Cefprozil—Hypersensitivity—Docetaxel—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Cefprozil—Convulsion—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Cefprozil—Pruritus—Docetaxel—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Cefprozil—Agitation—Doxorubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Cefprozil—Diarrhoea—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Cefprozil—Confusional state—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Cefprozil—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Cefprozil—Convulsion—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Cefprozil—Dizziness—Docetaxel—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefprozil—Thrombocytopenia—Epirubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Cefprozil—Vomiting—Docetaxel—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Cefprozil—Rash—Docetaxel—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Dermatitis—Docetaxel—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Confusional state—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Headache—Docetaxel—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefprozil—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Cefprozil—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefprozil—Insomnia—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Cefprozil—Somnolence—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Cefprozil—Nausea—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Cefprozil—Pain—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Cefprozil—Insomnia—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Cefprozil—Feeling abnormal—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefprozil—Somnolence—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Cefprozil—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Cefprozil—Urticaria—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Cefprozil—Pain—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefprozil—Abdominal pain—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefprozil—Body temperature increased—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Cefprozil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefprozil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefprozil—Hypersensitivity—Epirubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefprozil—Urticaria—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Cefprozil—Abdominal pain—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefprozil—Body temperature increased—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefprozil—Pruritus—Epirubicin—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefprozil—Diarrhoea—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefprozil—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefprozil—Dizziness—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefprozil—Pruritus—Doxorubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Cefprozil—Vomiting—Epirubicin—pancreatic cancer	0.000975	0.000975	CcSEcCtD
Cefprozil—Diarrhoea—Doxorubicin—pancreatic cancer	0.000971	0.000971	CcSEcCtD
Cefprozil—Rash—Epirubicin—pancreatic cancer	0.000967	0.000967	CcSEcCtD
Cefprozil—Dermatitis—Epirubicin—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Cefprozil—Headache—Epirubicin—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Cefprozil—Dizziness—Doxorubicin—pancreatic cancer	0.000939	0.000939	CcSEcCtD
Cefprozil—Nausea—Epirubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Cefprozil—Vomiting—Doxorubicin—pancreatic cancer	0.000903	0.000903	CcSEcCtD
Cefprozil—Rash—Doxorubicin—pancreatic cancer	0.000895	0.000895	CcSEcCtD
Cefprozil—Dermatitis—Doxorubicin—pancreatic cancer	0.000894	0.000894	CcSEcCtD
Cefprozil—Headache—Doxorubicin—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Cefprozil—Nausea—Doxorubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
